Literature DB >> 18789730

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.

Eynav Klechevsky1, Rimpei Morita, Maochang Liu, Yanying Cao, Sebastien Coquery, Luann Thompson-Snipes, Francine Briere, Damien Chaussabel, Gerard Zurawski, A Karolina Palucka, Yoram Reiter, Jacques Banchereau, Hideki Ueno.   

Abstract

Little is known about the functional differences between the human skin myeloid dendritic cell (DC) subsets, epidermal CD207(+) Langerhans cells (LCs) and dermal CD14(+) DCs. We showed that CD14(+) DCs primed CD4(+) T cells into cells that induce naive B cells to switch isotype and become plasma cells. In contrast, LCs preferentially induced the differentiation of CD4(+) T cells secreting T helper 2 (Th2) cell cytokines and were efficient at priming and crosspriming naive CD8(+) T cells. A third DC population, CD14(-)CD207(-)CD1a(+) DC, which resides in the dermis, could activate CD8(+) T cells better than CD14(+) DCs but less efficiently than LCs. Thus, the human skin displays three DC subsets, two of which, i.e., CD14(+) DCs and LCs, display functional specializations, the preferential activation of humoral and cellular immunity, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789730      PMCID: PMC2688399          DOI: 10.1016/j.immuni.2008.07.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  48 in total

1.  Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.

Authors:  Rhys S Allan; Jason Waithman; Sammy Bedoui; Claerwen M Jones; Jose A Villadangos; Yifan Zhan; Andrew M Lew; Ken Shortman; William R Heath; Francis R Carbone
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

2.  Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.

Authors:  Yukai He; Jiying Zhang; Cara Donahue; Louis D Falo
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

Review 3.  IL-17 family cytokines and the expanding diversity of effector T cell lineages.

Authors:  Casey T Weaver; Robin D Hatton; Paul R Mangan; Laurie E Harrington
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

4.  Differential antigen processing by dendritic cell subsets in vivo.

Authors:  Diana Dudziak; Alice O Kamphorst; Gordon F Heidkamp; Veit R Buchholz; Christine Trumpfheller; Sayuri Yamazaki; Cheolho Cheong; Kang Liu; Han-Woong Lee; Chae Gyu Park; Ralph M Steinman; Michel C Nussenzweig
Journal:  Science       Date:  2007-01-05       Impact factor: 47.728

5.  From vanilla to 28 flavors: multiple varieties of T regulatory cells.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

Review 6.  Translating innate immunity into immunological memory: implications for vaccine development.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

Review 7.  T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.

Authors:  Roy Noy; Malka Eppel; Maya Haus-Cohen; Einav Klechevsky; Orian Mekler; Yaeil Michaeli; Galit Denkberg; Yoram Reiter
Journal:  Expert Rev Anticancer Ther       Date:  2005-06       Impact factor: 4.512

Review 8.  Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.

Authors:  Shimon Sakaguchi; Masahiro Ono; Ruka Setoguchi; Haruhiko Yagi; Shohei Hori; Zoltan Fehervari; Jun Shimizu; Takeshi Takahashi; Takashi Nomura
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

Review 9.  Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

Authors:  Maria Grazia Roncarolo; Silvia Gregori; Manuela Battaglia; Rosa Bacchetta; Katharina Fleischhauer; Megan K Levings
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

10.  A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.

Authors:  Helena Soares; HaeNa Waechter; Nicholas Glaichenhaus; Evelyne Mougneau; Hideo Yagita; Olga Mizenina; Diana Dudziak; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Exp Med       Date:  2007-04-16       Impact factor: 14.307

View more
  267 in total

1.  Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

Authors:  Eynav Klechevsky; Anne-Laure Flamar; Yanying Cao; Jean-Philippe Blanck; Maochang Liu; Amy O'Bar; Olivier Agouna-Deciat; Peter Klucar; Luann Thompson-Snipes; Sandra Zurawski; Yoram Reiter; A Karolina Palucka; Gerard Zurawski; Jacques Banchereau
Journal:  Blood       Date:  2010-06-07       Impact factor: 22.113

Review 2.  Targeting human dendritic cell subsets for improved vaccines.

Authors:  Hideki Ueno; Eynav Klechevsky; Nathalie Schmitt; Ling Ni; Anne-Laure Flamar; Sandra Zurawski; Gerard Zurawski; Karolina Palucka; Jacques Banchereau; Sangkon Oh
Journal:  Semin Immunol       Date:  2011-01-28       Impact factor: 11.130

Review 3.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

4.  The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming.

Authors:  Jacques Banchereau; LuAnn Thompson-Snipes; Sandra Zurawski; Jean-Philippe Blanck; Yanying Cao; Sandra Clayton; Jean-Pierre Gorvel; Gerard Zurawski; Eynav Klechevsky
Journal:  Blood       Date:  2012-04-25       Impact factor: 22.113

5.  The expanding family of dendritic cell subsets.

Authors:  Hideki Ueno; A Karolina Palucka; Jacques Banchereau
Journal:  Nat Biotechnol       Date:  2010-08       Impact factor: 54.908

Review 6.  Programming dendritic cells to induce T(H)2 and tolerogenic responses.

Authors:  Bali Pulendran; Hua Tang; Santhakumar Manicassamy
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

7.  Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.

Authors:  Laura M Fahey; Adam B Raff; Diane M Da Silva; W Martin Kast
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

Authors:  Eynav Klechevsky; Maochang Liu; Rimpei Morita; Romain Banchereau; Luann Thompson-Snipes; A Karolina Palucka; Hideki Ueno; Jacques Banchereau
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

9.  Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

Authors:  YuFeng Peng; Yvette Latchman; Keith B Elkon
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 10.  New routes for allergen immunotherapy.

Authors:  Pål Johansen; Seraina von Moos; Deepa Mohanan; Thomas M Kündig; Gabriela Senti
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.